Tammi Cahill Tc Repair And Custom Designs Linkedin

1. Roden L, Campbell P, Fraser JR, Laurent TC, Pertoft H, Thompson JN. Enzymic pathways of hyaluronan catabolism. Ciba Found Symp 1989; 143:60-76.

2. Fraser JR, Brown TJ, Laurent TC. Catabolism of Hyaluronan. The Chemistry, Biology and Medical Applications of Hyaluronan and Its Derivatives. London: Portland Press, 1998; 92-95.

3. Laurent TC, Fraser JR. Hyaluronan. Faseb J 1992; 6:2397 -2404.

4. Knudson W, Chow G, Knudson CB. CD44-mediated uptake and degradation of hyaluronan. Matrix Biol 2002; 21:15-23.

5. Weigel PH, Yik JH. Glycans as endocytosis signals: the cases of the asialoglycoprotein and hyaluronan/chondroitin sulfate receptors. Biochim Biophys Acta 2002; 1572:341-363.

6. Tammi R, Saamanen AM, Maibach HI, Tammi M. Degradation of newly synthesized high molecular mass hyaluronan in the epidermal and dermal compartments of human skin in organ culture. J Investig Dermatol 1991; 97: 126-130.

7. Tammi R, Rilla K, Pienimaki JP, MacCallum DK, Hogg M, Luukkonen M, Hascall VC, Tammi M. Hyaluronan enters keratinocytes by a novel endocytic route for catabolism. J Biol Chem 2001; 276:35111-35122.

8. Knudson CB. Hyaluronan receptor-directed assembly of chondrocyte pericellular matrix. J Cell Biol 1993; 120:825-834.

9. Hua Q, Knudson CB, Knudson W. Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis. J Cell Sci 1993; 106:365-375.

10. Lesley J, English N, Charles C, Hyman R. The role of the CD44 cytoplasmic and transmembrane domains in constitutive and inducible hyaluronan binding. Eur J Immunol 2000; 30:245-253.

11. Tammi R, MacCallum D, Hascall VC, Pienimaki J, Hyttinen M, Tammi M. Hyaluronan bound to CD44 on keratinocytes is displaced by hyaluronan decasaccharides and not hexasaccharides. J Biol Chem 1998; 273:28878 -28888.

12. Tuhkanen AL, Agren UM, Tammi MI, Tammi RH. CD44 expression marks the onset of keratinocyte stratification and mesenchymal maturation into fibrous dermis in fetal human skin. J Histochem Cytochem 1999; 47:1617-1624.

13. Cichy J, Pure E. The liberation of CD44. J Cell Biol 2003; 161:839-843.

14. Sherman L, Sleeman J, Herrlich P, Ponta H. Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. Curr Opin Cell Biol 1994; 6:726-733.

15. Kaya G, Rodriguez I, Jorcano JL, Vassalli P, Stamenkovic I. Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation. Genes Dev 1997; 11:996-1007.

16. Fraser JR, Kimpton WG, Laurent TC, Cahill RN, Vakakis N. Uptake and degradation of hyaluronan in lymphatic tissue. Biochem J 1988; 256:153-158.

17. Fraser JR, Dahl LB, Kimpton WG, Cahill RN, Brown TJ, Vakakis N. Elimination and subsequent metabolism of circulating hyaluronic acid in the fetus. J Dev Physiol 1989; 11:235-242.

18. Eriksson S, Fraser JR, Laurent TC, Pertoft H, Smedsrod B. Endothelial cells are a site of uptake and degradation of hyaluronic acid in the liver. Exp Cell Res 1983; 144:223-228.

19. Yannariello Brown J, Frost SJ, Weigel PH. Identification of the Ca(2 + )-independent endocytic hyaluronan receptor in rat liver sinusoidal endothelial cells using a photoaffinity cross-linking reagent. J Biol Chem 1992; 267: 20451-20456.

20. Zhou B, Oka JA, Singh A, Weigel PH. Purification and subunit characterization of the rat liver endocytic hyaluronan receptor. J Biol Chem 1999; 274:33831-33834.

21. Weigel JA, Raymond RC, McGary C, Singh A, Weigel PH. A blocking antibody to the hyaluronan receptor for endocytosis (HARE) inhibits hyaluronan clearance by perfused liver. J Biol Chem 2003; 278:9808-9812.

22. Politz O, Gratchev A, McCourt PA, Schledzewski K, Guillot P, Johansson S, Svineng G, Franke P, Kannicht C, Kzhyshkowska J, Longati P, Velten FW, Goerdt S. Stabilin-1 and -2 constitute a novel family of fasciclin-like hyaluronan receptor homologues. Biochem J 2002; 362:155-164.

23. Tamura Y, Adachi H, Osuga J, Ohashi K, Yahagi N, Sekiya M, Okazaki H, Tomita S, Iizuka Y, Shimano H, Nagai R, Kimura S, Tsujimoto M, Ishibashi S. FEEL-1 and FEEL-2 are endocytic receptors for advanced glycation end products. J Biol Chem 2003; 278:12613-12617.

24. Zhou B, Weigel JA, Saxena A, Weigel PH. Molecular cloning and functional expression of the rat 175-kDa hyaluronan receptor for endocytosis. Mol Biol Cell 2002; 13:2853-2868.

25. Zhou B, Weigel JA, Fauss L, Weigel PH. Identification of the hyaluronan receptor for endocytosis (HARE). J Biol Chem 2000; 275:37733-37741.

26. Banerji S, Ni J, Wang SX, Clasper S, Su J, Tammi R, Jones M, Jackson DG. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999; 144:789-801.

27. Mouta Carreira C, Nasser SM, di Tomaso E, Padera TP, Boucher Y, Tomarev SI, Jain RK. LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Res 2001; 61:8079-8084.

28. Jackson DG. The lymphatics revisited: new perspectives from the hyaluronan receptor LYVE-1. Trends Cardiovasc Med 2003; 13:1-7.

29. Prevo R, Banerji S, Ferguson DJ, Clasper S, Jackson DG. Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J Biol Chem 2001; 276:19420-19430.

30. Kohda D, Morton CJ, Parkar AA, Hatanaka H, Inagaki FM, Campbell ID, Day AJ. Solution structure of the link module: a hyaluronan-binding domain involved in extracellular matrix stability and cell migration. Cell 1996; 86:767-775.

31. Day AJ. The structure and regulation of hyaluronan-binding proteins. Biochem Soc Trans 1999; 27:115-121.

32. Salustri A, Camaioni A, Di Giacomo M, Fulop C, Hascall VC. Hyaluronan and proteoglycans in ovarian follicles. Hum Reprod Update 1999; 5:293-301.

33. Primakoff P, Hyatt H, Myles DG. A role for the migrating sperm surface antigen PH-20 in guinea pig sperm binding to the egg zona pellucida. J Cell Biol 1985; 101: 2239-2244.

34. Gmachl M, Sagan S, Ketter S, Kreil G. The human sperm protein PH-20 has hyaluronidase activity. FEBS Lett 1993; 336:545-548.

35. Jones MH, Davey PM, Aplin H, Affara NA. Expression analysis, genomic structure, and mapping to 7q31 of the human sperm adhesion molecule gene SPAM1. Genomics 1995; 29:796-800.

36. Baba D, Kashiwabara S, Honda A, Yamagata K, Wu Q, Ikawa M, Okabe M, Baba T. Mouse sperm lacking cell surface hyaluronidase PH-20 can pass through the layer of cumulus cells and fertilize the egg. J Biol Chem 2002; 277:30310-30314.

37. Lepperdinger G, Strobl B, Kreil G. HYAL2, a human gene expressed in many cells, encodes a lysosomal hyaluronidase with a novel type of specificity. J Biol Chem 1998; 273:22466-22470.

38. Mullegger J, Reitinger S, Lepperdinger G. Hapten-labeled hyaluronan, a substrate to monitor hyaluronidase activity by enhanced chemiluminescence-assisted detection on filter blots. Anal Biochem 2001; 293:291-293.

39. Mullegger J, Lepperdinger G. Degradation of hyaluronan by a Hyal2-type hyaluronidase affects pattern formation of vitelline vessels during embryogenesis of Xenopus laevis. Mech Dev 2002; 111:25-35.

40. Rai SK, Duh FM, Vigdorovich V, Danilkovitch-Miagkova A, Lerman MI, Miller AD. Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation. Proc Natl Acad Sci USA 2001; 98: 4443-4448.

41. Reitinger S, Mullegger J, Lepperdinger G. Xenopus kidney hyaluronidase-1 (XKH1), a novel type of membrane-bound hyaluronidase solely degrades hyaluronan at neutral pH. FEBS Lett 2001; 505:213-216.

42. Bonner WM Jr, Cantey EY. Colorimetric method for determination of serum hyaluronidase activity. Clin Chim Acta 1966; 13:746-752.

43. Fiszer-Szafarz B, Litynska A, Zou L. Human hyaluronidases: electrophoretic multiple forms in somatic tissues and body fluids. Evidence for conserved hyaluronidase potential N-glycosylation sites in different mammalian species. J Biochem Biophys Methods 2000; 45:103-116.

44. Frost GI, Csoka TB, Wong T, Stern R. Purification, cloning, and expression of human plasma hyaluronidase. Biochem Biophys Res Commun 1997; 236:10-15.

45. Csoka TB, Frost GI, Wong T, Stern R. Purification and microsequencing of hyaluronidase isozymes from human urine. FEBS Lett 1997; 417:307-310.

46. Lokeshwar VB, Young MJ, Goudarzi G, Iida N, Yudin AI, Cherr GN, Selzer MG. Identification of bladder tumor-derived hyaluronidase: its similarity to HYAL1. Cancer Res 1999; 59:4464-4470.

47. Podyma KA, Yamagata S, Sakata K, Yamagata T. Difference of hyaluronidase produced by human tumor cell lines with hyaluronidase present in human serum as revealed by zymography. Biochem Biophys Res Commun 1997; 241:446-452.

48. Afify AM, Stern M, Guntenhoner M, Stern R. Purification and characterization of human serum hyaluronidase. Arch Biochem Biophys 1993; 305:434-441.

49. Natowicz MR, Short MP, Wang Y, Dickersin GR, Gebhardt MC, Rosenthal DI, Sims KB, Rosenberg AE. Clinical and biochemical manifestations of hyaluronidase deficiency. N Engl J Med 1996; 335:1029-1033.

50. Triggs-Raine B, Salo TJ, Zhang H, Wicklow BA, Natowicz MR. Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopoly-saccharidosis IX. Proc Natl Acad Sci USA 1999; 96:6296-6300.

51. Stern R. Devising a pathway for hyaluronan catabolism: are we there yet? Glycobiology 2003; 13:105R-115R.

52. McGuire PG, Castellot JJ Jr, Orkin RW. Size-dependent hyaluronate degradation by cultured cells. J Cell Physiol 1987; 133:267-276.

53. Phillips GO. Degradation of hyaluronansystems by free radicals. In: Laurent TC, ed. The Chemistry, Biology and Medical Applications of Hyaluronan and Its Derivatives. London: Portland Press, 1998:93-112.

54. Al-Assaf S, Meadows J, Phillips GO, Williams PA, Parsons BJ. The effect of hydroxyl radicals on the rheological performance of hylan and hyaluronan. Int J Biol Macromol 2000; 27:337-348.

55. Al-Assaf S, Navaratnam S, Parsons BJ, Phillips GO. Chain scission of hyaluronan by peroxynitrite. Arch Biochem Biophys 2003; 411:73-82.

56. Flugge LA, Miller-Deist LA, Petillo PA. Towards a molecular understanding of arthritis. Chem Biol 1999; 6:R157-R166.

57. Coleman PJ, Scott D, Mason RM, Levick JR. Role of hyaluronan chain length in buffering interstitial flow across synovium in rabbits. J Physiol (Lond) 2000; 526: 425 -434.

Chemistry and Biology of Hyaluronan H.G. Garg and C.A. Hales (editors) © 2004 Elsevier Ltd. All rights reserved.

Was this article helpful?

0 0
Natural Arthritis Relief

Natural Arthritis Relief

Natural Arthritis Relief details a unique method of reversing Rheumatoid Arthritis Symptoms by removing numerous arthritis triggers as well as toxins using a simple 5 step natural process.

Get My Free Ebook

Post a comment